Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells
Omidreza Firuzi(Shiraz University of Medical Sciences), Elisa Giovannetti(University of Pisa)
Cited by 76
Related Papers
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
|Critical Reviews in Clinical Laboratory Sciences|2019|182
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
|Journal of Hematology & Oncology|2017|84
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
|Oncotarget|2015|31